ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

ACCC Honors Hammond, Murphy

October 19, 2001

Research: No Increase in Cancer Deaths Found at Three Mile Island

May 5, 2000

NCI Considers Making Prevention Trial From NSABP; Other Groups Approached

May 13, 1994

Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget

March 15, 1974

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997